Clinical Trials Directory

Trials / Conditions / aGVHD

aGVHD

13 registered clinical trials studyying aGVHD4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplanta
NCT07381114
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1 / Phase 2
RecruitingBPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantati
NCT07246031
BioPhoenix Co., Ltd.Phase 2
Not Yet RecruitingStudy of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease
NCT07185633
Bin GuPhase 2
RecruitingCo-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
NCT06904482
Case Comprehensive Cancer CenterPhase 2
UnknownUmbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Diseas
NCT05531266
Institute of Hematology & Blood Diseases Hospital, ChinaN/A
TerminatedA Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus H
NCT05263999
EquilliumPhase 3
CompletedFirst Line Therapy for High Risk Acute GVHD
NCT04061876
Chinese PLA General HospitalPhase 2
CompletedA Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD
NCT03763318
EquilliumPhase 1 / Phase 2
UnknownEfficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
NCT05214066
Chinese PLA General HospitalPhase 2
CompletedLow Dose Ruxolitinib in Combination With Methylprednisolone
NCT04397367
Chinese PLA General HospitalPhase 1 / Phase 2
UnknownBiomarker Study for Prediction of aGVHD
NCT03614143
Shanghai Jiao Tong University School of Medicine
UnknownValproic Acid With Methylprenisonlone for the Treatment of Acute GVHD
NCT02848105
Shanghai Jiao Tong University School of MedicinePhase 2
CompletedEfficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
NCT02677181
Chinese PLA General HospitalPhase 4